Australian Clinical Labs Limited (ASX: ACL)
Australia flag Australia · Delayed Price · Currency is AUD
3.470
+0.050 (1.46%)
Nov 21, 2024, 4:10 PM AEST

Australian Clinical Labs Company Description

Australian Clinical Labs Limited provides pathology diagnostic services in Australia.

The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services.

It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Australian Clinical Labs Limited
Country Australia
Founded 2020
Industry Diagnostics & Research
Sector Healthcare
Employees 4,900
CEO Melinda McGrath

Contact Details

Address:
1868-1892 Dandenong Road
Clayton, 3168
Australia
Phone 61 1 3004 53688
Website clinicallabs.com.au

Stock Details

Ticker Symbol ACL
Exchange Australian Securities Exchange
Fiscal Year July - June
Reporting Currency AUD
ISIN Number AU0000148496
SIC Code 8071

Key Executives

Name Position
Shae Seymour Chief Executive Officer of WA/SA/NT
Chris Brownlow Chief Executive Officer of New South Wales and Australian Capital Territory
Darren McKee Chief Executive Officer of Victoria
Melinda McGrath Chief Executive Officer and Executive Director
Matthew Cordingley Chief Financial Officer
Anthony Friedli Chief Operating Officer
Sean Jackson Chief Information Officer
Joe Geran National Marketing Director
Associate Prof. Tony Landgren National Medical Director and Chief Pathologist
Eleanor Padman B.A., FCIS Company Secretary